A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction ...

Helicore Biopharma has dosed the first subject in the randomised first-in-human Phase I trial of HCR-188 to treat obesity.

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, drugmaker Johnson & Johnson announced on Thursday. An interleukin (IL)-23 ...

The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced that Novo Nordisk and TUL’s wholly-owned subsidiary The United Bio-Technology (Hengqin) ...

North Carolina's life sciences ecosystem is thriving, thanks in no small part to the leadership and innovation of women ...

Importantly, the fully subcutaneous regimen offers choice ... included respiratory tract infections, abdominal pain, injection site reactions, headache, fatigue, arthralgia, diarrhea, and ...

Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

The biotechnology company CD Formulation now offers advanced microneedle technology services specifically designed for cosmetic industry needs. CD Formulation continues to demonstrate its dedication ...

We are pleased to welcome Preetam to Elicio’s executive team,” said Robert Connelly, Ph.D., President and Chief Executive Officer of Elicio. “He joins us during an exciting time. We remain encouraged ...